...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients

Just a quick note to reply to, and thx those who took the time to read my ranting post today.  Indeed, it seems we are all pretty much aligned.  

Appreciate all of those who replied!  
Let's goooo!!!

10BagR

Share
New Message
Please login to post a reply